Andreae-Noris Zahn AG
Pharmaceutical Wholesale · Frankfurt am Main
Andreae-Noris Zahn AG is a licensed pharmaceutical wholesaler in Frankfurt am Main, Hessen, supplying pharmacies and hospitals with medicines and healthcare products.
Content in German
The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.
Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.
Andreae-Noris Zahn AG Address & Contact
Website
Andreae-Noris Zahn AG Overview
The Andreae-Noris Zahn AG (ANZAG) is an established pharmaceutical wholesaler headquartered in Frankfurt am Main, Hesse. Founded in 1872, the company has a long history in the field of drug supply. With over 150 years of experience, ANZAG is considered one of the leading pharmaceutical wholesalers in Germany. The company supplies pharmacies and clinics throughout the Rhine-Main area and beyond nationwide. Reliable organization and compliance with the highest legal standards are the foundations on which ANZAG's services are built. The company is particularly focused on distributing pharmaceuticals and other medical products in accordance with the strict regulations of the German Medicines Act.
Importance of Pharmaceutical Wholesaling
Pharmaceutical wholesaling is a crucial interface in drug supply. Andreae-Noris Zahn AG ensures that a smooth flow of medications is maintained between manufacturers and pharmacies, so that they reach patients in a timely manner and in impeccable quality. Pharmaceutical distribution companies are not only responsible for the storage and transport of the products but must also ensure that all legal regulations are complied with. These companies are subject to the obligation of GDP certification (Good Distribution Practice) according to EU directive and require a license in accordance with § 52a AMG. This ensures that pharmaceuticals are stored and transported under optimal conditions, thereby guaranteeing the quality and safety of the products. Therefore, ANZAG plays a fundamental role in Germany's healthcare system and contributes to the overall health of the population.
Supply Area Frankfurt am Main and Hesse
From its strategically located base in Frankfurt am Main, the Andreae-Noris Zahn AG supplies pharmacies and medical facilities across Hesse. Customers benefit from a reliable daily supply tailored to the specific needs of the regions. The enormous logistics capabilities of the company allow for demand-oriented deliveries, which make clinical and pharmacy facilities in the region continually rely on ANZAG's excellent services. The company maintains close relationships with its customers and promotes communication to develop optimal supply strategies.
Products and Services
The Andreae-Noris Zahn AG offers a comprehensive portfolio of products, which includes prescription medications as well as over-the-counter drugs, medical aids, and health products. This includes commonly used drugstore items as well as the latest innovations in the pharmaceutical industry. ANZAG ensures that all items are in compliance with current medical and technological standards.
In addition to product distribution, the company also offers extensive services tailored to the needs of its customers. These include consulting on medication therapy, support in optimizing inventory management, and rapid delivery options specifically designed for customers with urgent needs. The flexibility in order processing and the always modern warehouse technologies enable ANZAG to respond quickly to the needs of pharmacies and clinics.
Unique Features and Innovation Power
A standout feature of the Andreae-Noris Zahn AG is the continuous innovation capability of the company. Year after year, ANZAG invests in modernizing its storage and logistics processes to offer even more efficient solutions. As part of these investments, a state-of-the-art, automated warehouse has been developed, allowing for faster and more precise management of the multitude of products. This significantly reduces delivery times and improves overall efficiency.
Moreover, the Andreae-Noris Zahn AG is strongly involved in regional health initiatives. The company supports numerous local health promotion projects and actively works towards improving public health. These measures demonstrate ANZAG's commitment to acting not only as a service provider but also as a responsible member of the community.
Regulatory Classification and Challenges
In Germany, the Andreae-Noris Zahn AG is subject to strict regulatory frameworks that affect drug supply. The approval according to § 52a AMG must not only be obtained for distribution but also includes ongoing quality controls and safety tests. The challenges in pharmaceutical wholesaling are diverse, including intense competition, rising costs, and demanding legal requirements. Nevertheless, ANZAG has successfully mastered these challenges and has established itself as a competent partner for pharmacies and clinics.
Overall, the Andreae-Noris Zahn AG is an indispensable player in the German pharmaceutical wholesaling, whose significance extends beyond Frankfurt am Main.
All contact information for Andreae-Noris Zahn AG can be found on this Sanoliste page.
Frequently asked questions about Andreae-Noris Zahn AG
Wer ist Andreae-Noris Zahn AG?
Andreae-Noris Zahn AG ist ein nach § 52a AMG genehmigter Pharmagroßhändler in Frankfurt am Main, Hessen, der Apotheken, Krankenhäuser und andere Gesundheitseinrichtungen beliefert.
Was liefert Andreae-Noris Zahn AG?
Andreae-Noris Zahn AG liefert Arzneimittel, Medizinprodukte, OTC-Präparate sowie Apothekenbedarf an Kunden in Hessen und angrenzenden Regionen.
Wo ist Andreae-Noris Zahn AG erreichbar?
Andreae-Noris Zahn AG hat seinen Standort in Frankfurt am Main, Hessen. Adresse und Kontaktdaten finden Sie auf dieser Sanoliste-Seite.
Pharmaceutical Wholesale in Germany
Related areas in healthcare
Pharmaceutical Wholesale by location
About Pharmaceutical Wholesale
Pharmaceutical wholesalers (Pharmagrosshandel) form the critical supply chain link between medicine manufacturers and authorised recipients such as pharmacies (Apotheken), hospitals (Krankenhäuser), medical practices and other licensed healthcare facilities. In Germany, the commercial distribution of medicinal products at wholesale level is a strictly regulated, licence-dependent activity. Every pharmaceutical wholesaler must hold a wholesale dealer authorisation (Großhandelserlaubnis) granted under Section 52a of the AMG (German Medicinal Products Act). This authorisation is issued by the pharmaceutical supervisory authority of the relevant German federal state and requires applicants to demonstrate suitable temperature-controlled storage premises, a documented quality management system, a qualified responsible person (verantwortliche Person), and ongoing compliance with the EU Good Distribution Practice (GDP) guidelines. Full-line wholesalers (Vollsortimenter) stock virtually the entire range of authorised medicines available in Germany, whereas specialist wholesalers focus on particular therapeutic areas or logistics requirements such as cold chain products, controlled substances (Betäubungsmittel) or imported parallel-trade medicines. Nationwide, around 15 full-line wholesalers and over 100 specialist wholesalers collectively ensure comprehensive medicine supply to more than 18,000 pharmacies across the country. This directory lists all authorised pharmaceutical wholesalers in Germany holding a valid authorisation under Section 52a AMG, with addresses and full contact details.
The Role of Pharmaceutical Wholesale in Germany's Medicine Supply
Germany's pharmaceutical wholesale sector is the backbone of the country's medicine distribution system, ensuring that more than 18,000 pharmacies and thousands of hospitals receive their medicine supplies reliably, often within hours of ordering. The German wholesale model is built around a hub-and-spoke logistics system: large national full-line wholesalers (Vollsortimenter) operate central and regional warehouses that stock virtually the entire range of authorised medicines. From these warehouses, medicines are delivered to pharmacies typically two or three times per day by refrigerated vans. This high delivery frequency means that pharmacies can operate with lean stock levels while still being able to fill patient prescriptions on the same day. Germany's medicine supply chain performed robustly during the COVID-19 pandemic, demonstrating the resilience of its wholesale infrastructure. The three largest full-line wholesalers in Germany collectively hold a dominant market share, but they compete with each other and with smaller regional and specialist wholesalers.
Legal Requirements Under Section 52a AMG and EU GDP
Operating as a pharmaceutical wholesaler in Germany requires a wholesale dealer authorisation (Großhandelserlaubnis) granted by the competent pharmaceutical supervisory authority of the relevant German federal state under Section 52a of the AMG. This authorisation is not automatic and requires applicants to demonstrate compliance with a detailed set of prerequisites before trading can begin. The premises must be suitable for temperature-controlled storage, with validated temperature mapping studies for all storage areas. A documented quality management system (QMS) must be in place covering procurement, storage, pick and dispatch, complaints, returns, recalls, counterfeiting detection and self-inspections. A qualified responsible person (verantwortliche Person) with the relevant pharmaceutical or scientific qualifications must be designated and approved by the authority. After authorisation is granted, companies must comply with the EU GDP guidelines (EudraLex Volume 5), which are periodically updated. Inspections by the state pharmaceutical authority verify ongoing compliance.
Specialist Wholesale and Cold Chain Logistics in Germany
Beyond full-line wholesale, Germany has a developed specialist wholesale sector catering to specific product categories that require particular expertise or infrastructure. Cold chain wholesale is especially important for biological medicines including monoclonal antibodies, vaccines, insulin and plasma-derived products, which must be stored and transported within defined temperature ranges (typically 2 to 8 degrees Celsius). Controlled substance (Betäubungsmittel) wholesale requires additional authorisation under the Betäubungsmittelgesetz (BtMG) and is subject to strict record-keeping and security requirements. Import wholesale specialises in parallel-imported medicines, sourcing products authorised in other EU member states at lower prices and relabelling them in accordance with German regulatory requirements. Specialty pharmacy wholesale focuses on high-value oncology drugs, immunosuppressants and rare disease treatments. Each of these specialist segments requires specific expertise, infrastructure and additional regulatory permissions beyond the standard Section 52a AMG authorisation.
Medicinal Product Supply Chain Security and Falsification Protection
The integrity of the pharmaceutical supply chain is a central responsibility of pharmaceutical wholesale. Since February 2019, the EU Falsified Medicines Directive (FMD) has been fully in force: every prescription medicinal product pack carries an individual 2D data matrix code, which is scanned and verified at the wholesaler and end recipient in the national verification database (in Germany: securPharm). Temperature-critical products, including biologics, insulins and vaccines, require an unbroken cold chain (2–8 °C or frozen), which the wholesaler ensures with validated cold stores, temperature-controlled transport and temperature monitoring. Controlled substances are additionally subject to the Narcotics Act (BtMG) with strict documentation requirements. Recall management and batch traceability in accordance with GDP guidelines are mandatory. Sanoliste identifies specialist wholesalers for cold chain, controlled substances and parallel import medicines separately.
What does a pharmaceutical wholesaler do?
Pharmaceutical wholesalers procure, store and distribute medicines to pharmacies, hospitals and other authorised recipients. In Germany, wholesale trade in medicines requires authorisation under Section 52a AMG.
What authorisation does a pharmaceutical wholesaler need?
A pharmaceutical wholesaler must hold authorisation under Section 52a of the AMG (German Medicinal Products Act). Requirements include suitable premises, a qualified responsible person and compliance with EU Good Distribution Practice (GDP) guidelines.
How do I find an authorised pharmaceutical wholesaler in Germany?
Authorised pharmaceutical wholesalers are registered with the competent state authority under Section 52a AMG. Sanoliste lists all wholesalers with valid authorisation, including specialisations in cold chain logistics, controlled substances or imported medicines. Filter by federal state for a regional search.
How many pharmaceutical wholesalers are there in Germany?
Germany has approximately 15 full-line pharmaceutical wholesalers (Vollsortimenter) that stock the full range of authorised medicines and deliver to pharmacies nationwide, alongside more than 100 specialist wholesalers focusing on specific therapeutic areas, temperature-sensitive biologics or controlled substances. Together they supply over 18,000 pharmacies across the country.
What does EU Good Distribution Practice (GDP) require?
The EU GDP guidelines (2013/C 343/01) set out requirements for the proper distribution of medicinal products. For pharmaceutical wholesalers this includes maintaining appropriate temperature-controlled storage conditions (especially for cold-chain products), operating a documented quality management system, training qualified personnel, conducting supplier and customer qualification audits, maintaining full traceability records, and having procedures for handling suspected counterfeits, complaints and recalls.
Can a pharmaceutical wholesaler in Germany supply directly to patients?
No. In Germany, pharmaceutical wholesalers are not permitted to supply medicines directly to patients. They may only supply authorised recipients such as pharmacies, hospitals, medical practices (under specific conditions) and other licensed wholesalers. Patients must obtain prescription medicines through a pharmacy, which in turn sources its stock from authorised wholesalers or directly from manufacturers.
What is the difference between a pharmaceutical wholesaler and a medicine broker?
A pharmaceutical wholesaler physically holds medicines in stock, stores them and delivers to authorised recipients such as pharmacies and hospitals. They require a wholesale authorisation under § 52a AMG and must maintain GDP-compliant storage conditions. A medicine broker, by contrast, does not take possession of medicines but merely arranges transactions between manufacturers, wholesalers and buyers. Brokering activities are subject to registration under § 52b AMG.